Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Rebamipide in Patients With Active Rheumatoid Arthritis [Phase 1, Phase 2]
This document provides an update on a Phase 1/Phase 2 trial evaluating Rebamipide in patients with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis [Phase 1]
Phase 1 clinical trial assessing the safety and pharmacokinetics of LPX-TI641 in patients with rheumatoid arthritis and psoriatic arthritis,…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid Arthritis
Pfizer-sponsored study in Colombian patients evaluating adherence and clinical outcomes with an electronic device for administering etanerce…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65
A prospective study of rheumatoid arthritis in patients over 65 has been terminated.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Dynamic Treatment Regiments for Glucocorticoid Tapering [Phase 2]
Phase 2 clinical trial in rheumatoid arthritis evaluating dynamic glucocorticoid tapering regimens. The study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Cardiovascular Disease Awareness in Rheumatoid Arthritis and Knee Osteoarthritis
A completed clinical trial evaluating cardiovascular disease awareness among people with rheumatoid arthritis and knee osteoarthritis.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]
A Phase 2 study evaluating the long-term safety and efficacy of ABX464 in patients with moderate-to-severe rheumatoid arthritis has complete…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets
A real-world study in Japan assessed the frequency of serious infections among adults with rheumatoid arthritis receiving Rinvoq (upadacitin…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects [Phase 1]
Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-3045 in healthy subjects; rheumatoid arthr…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology [NA]
A completed rheumatology pilot trial evaluating an intervention to break implicit bias habits through individuation, with results posted.
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors
Boehringer Ingelheim completed a study to develop a screening tool for detecting interstitial lung disease in people with rheumatoid arthrit…
-
EMA approval · 2025-11-10EMA Authorised: Flixabi (infliximab) — Samsung Bioepis NL B.V.
The EMA authorised Flixabi, a biosimilar of infliximab, for several inflammatory diseases. The indications include rheumatoid arthritis, pso…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
A clinical trial is evaluating an educational tool to help melanoma patients with pre-existing autoimmune diseases who are candidates for im…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
This clinical trial update describes a study comparing guided care using the Vectra biomarker test to treatment as usual in rheumatoid arthr…
-
FDA approval · 2025-11-04FDA Approved: SULFASALAZINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for sulfazalasine (sulfasalazine) manufactured by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance
The clinical trial NCT01180361 investigating atherosclerosis in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Database Retrieval for the Comprehensive Shoulder
Clinical trial update for Zimmer Biomet's Comprehensive Shoulder shows multiple shoulder conditions listed and the trial status is active bu…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting [Phase 1, Phase 2]
This Phase 1/2 clinical trial update describes enrollment for a Quantum-Synaptic Immunotherapy approach that uses low-frequency electromagne…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty [NA]
A post-market clinical study evaluating the reverse augmented glenoid and mini humeral tray used in total shoulder arthroplasty.
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Zimmer Trabecular Metal Total Ankle PMCF [NA]
Clinical trial update shows the Zimmer Trabecular Metal Total Ankle PMCF study is currently active but not recruiting, evaluating use in ost…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Clinical trial update indicating the Trabecular Metal Reverse Shoulder System outcomes study by Zimmer Biomet is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Clinical Outcomes Study of the Nexel Total Elbow [NA]
ClinicalTrials.gov registry entry for a prospective outcomes study of the Nexel Total Elbow device by Zimmer Biomet, currently recruiting fo…
-
FDA approval · 2025-10-28FDA Approved: RENFLEXIS — Supplemental Application (Organon LLC)
FDA approved a supplemental application for RENFLEXIS (infliximab) submitted by Organon LLC. The approval updates the product labeling to re…
-
FDA approval · 2025-10-24FDA Approved: LEFLUNOMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Leflunomide filed by Chartwell RX, LLC under ANDA077086.
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Persona Ti-Nidium Post-Market Clinical Follow-up [NA]
Zimmer Biomet's Persona Ti-Nidium post-market follow-up trial is active but not recruiting, focusing on knee-related conditions such as oste…